{"transactions":[{"id":4635770,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-10-06T12:00:20.000Z","date":"2025-12-19","kind":"other","planned":false,"acquired":false,"price":0,"reported_value":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On December 19, 2025, the Convertible Promissory Note was paid in full."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents the maturity date of the Convertible Promissory Note."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":1.785,"exercise_date":"2025-07-21","expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":56023},"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":4635769,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T12:00:20.000Z","date":"2026-08-11","kind":"gift","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein."}],"balance_after":3305000,"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":4635768,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T12:00:20.000Z","date":"2026-08-11","kind":"gift","planned":false,"acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":4635767,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T12:00:20.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Issuable to Mr. Cohen as a bonus in lieu of a change of control payment which would have otherwise been due under this Employment Agreement."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":4635766,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T12:00:20.000Z","date":"2025-09-30","kind":"gift","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein."}],"balance_after":1305000,"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":4635765,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T12:00:20.000Z","date":"2025-09-30","kind":"gift","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-26-045858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1974475/000149315226045858/ownership.xml","form_type":"4"}},{"id":832287,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:40.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vest over 18 months with 500,000 of the options vesting upon grant and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":2000000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832286,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2026-03-20T17:00:40.000Z","date":"2025-07-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the \"A&R Note\"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the \"A&R Note\"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee (\"Tiger Cub\"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein."}],"balance_after":50000,"derivative":{"exercise_price":1.85,"exercise_date":"2025-07-21","expiration_date":"2028-07-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832285,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Promissory Note","published_at":"2026-03-20T17:00:40.000Z","date":"2025-07-21","kind":"grant","planned":false,"acquired":true,"reported_value":100000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the \"A&R Note\"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the \"A&R Note\"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents the maturity date of the Convertible Promissory Note."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee (\"Tiger Cub\"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":1.785,"exercise_date":"2025-07-21","expiration_date":"2026-05-02","underlying":"Common Stock","underlying_shares":56023},"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832284,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T17:00:40.000Z","date":"2025-09-09","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":500000,"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832283,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T17:00:40.000Z","date":"2025-06-05","kind":"gift","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee (\"Tiger Cub\"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein."}],"balance_after":805000,"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832282,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T17:00:40.000Z","date":"2025-06-05","kind":"gift","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-26-011921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011921/ownership.xml","form_type":"4"}},{"id":832281,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":2000000,"derivative":{"exercise_price":0.45,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":832280,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":2.3,"expiration_date":"2035-09-09","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":832279,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":83333,"derivative":{"exercise_price":0.45,"exercise_date":"2023-12-28","expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":832278,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":4.8,"exercise_date":"2023-12-28","expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":832277,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":0.45,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":832276,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T17:00:28.000Z","date":"2026-03-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the \"Repricing\") whereby the Reporting Person's options were repriced on March 16, 2026 (the \"Effective Date\") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":16.5,"expiration_date":"2027-09-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-26-011914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315226011914/ownership.xml","form_type":"4"}},{"id":1030505,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T16:59:58.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001493152-25-016352","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315225016352/ownership.xml","form_type":"4"}},{"id":1173253,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-04-11T17:00:13.000Z","date":"2025-04-10","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001641172-25-003873","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000164117225003873/ownership.xml","form_type":"4"}},{"id":1421839,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T19:41:46.000Z","date":"2024-08-26","kind":"gift","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein."}],"balance_after":9075000,"source":{"system":"sec-edgar","filing":"0001493152-24-034060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315224034060/ownership.xml","form_type":"4"}},{"id":1421838,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T19:41:46.000Z","date":"2024-08-26","kind":"gift","planned":false,"acquired":false,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represents Mr. Cohen's direct ownership of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-034060","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315224034060/ownership.xml","form_type":"4"}},{"id":1489894,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T17:15:21.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued as a bonus for fiscal 2024 for compensation as an officer of the Company. Granted under the Registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held directly by Mr. Cohen."}],"balance_after":800000,"source":{"system":"sec-edgar","filing":"0001493152-24-022803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315224022803/ownership.xml","form_type":"4"}},{"id":1697869,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T21:52:36.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Granted in consideration for services rendered as an officer of the Registrant. Granted under the Registrant's 2022 Equity Incentive Plan."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Held directly by Mr. Cohen."}],"balance_after":1250000,"derivative":{"exercise_price":0.32,"exercise_date":"2023-12-28","expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001493152-23-046643","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223046643/ownership.xml","form_type":"4"}},{"id":1908154,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:50:44.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":275000,"price":1,"value":275000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares acquired in a private transaction."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee."}],"balance_after":8275000,"source":{"system":"sec-edgar","filing":"0001493152-23-015227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223015227/ownership.xml","form_type":"4"}},{"id":1908153,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:50:44.000Z","date":"2023-04-04","kind":"gift","planned":false,"acquired":true,"shares":8000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee."}],"balance_after":8000000,"source":{"system":"sec-edgar","filing":"0001493152-23-015227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223015227/ownership.xml","form_type":"4"}},{"id":1908152,"issuer":{"id":8073,"kind":"organization","name":"MANGOCEUTICALS, INC.","symbol":"MGRX"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":56820,"kind":"organization","name":"Tiger Cub Trust","position":2,"cik":"0001974475","reported_name":"Tiger Cub Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T20:50:44.000Z","date":"2023-04-04","kind":"gift","planned":false,"acquired":false,"shares":8000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of Cohen Enterprises, Inc, which entity Mr. Cohen controls and which shares he is deemed to beneficially own."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-015227","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223015227/ownership.xml","form_type":"4"}},{"id":1920287,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-04-13T17:29:49.000Z","date":"2023-02-15","kind":"other","planned":false,"acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding."},{"field":"kind","element":"transactionCoding","label":"F7","text":"On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the \"Exchange Agreement\"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the \"Exchange Agreement\"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-06","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001493152-23-012179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223012179/ownership.xml","form_type":"4"}},{"id":1920286,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-04-13T17:29:49.000Z","date":"2022-05-06","kind":"other","planned":false,"acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the \"Restated Designation\"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the \"Restated Designation\"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer."}],"balance_after":1000000,"derivative":{"exercise_date":"2022-05-06","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001493152-23-012179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223012179/ownership.xml","form_type":"4"}},{"id":1920285,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-13T17:29:49.000Z","date":"2022-12-31","kind":"grant","planned":false,"acquired":true,"shares":6000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3."}],"balance_after":6458333,"source":{"system":"sec-edgar","filing":"0001493152-23-012179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223012179/ownership.xml","form_type":"4"}},{"id":1920284,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-04-13T17:29:49.000Z","date":"2022-05-06","kind":"other","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-012179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315223012179/ownership.xml","form_type":"4"}},{"id":2430276,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-20T16:00:42.000Z","date":"2022-01-12","kind":"grant","acquired":true,"shares":5000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for entering into Executive Employment Agreement of even date with issuance. Exempt under Rule 16b-3(d)."}],"balance_after":27500000,"source":{"system":"sec-edgar","filing":"0001493152-22-001719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315222001719/ownership.xml","form_type":"4"}},{"id":2757549,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-05T06:15:25.000Z","date":"2021-01-22","kind":"grant","acquired":true,"shares":2500000,"price":0.38,"value":950000.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for services rendered as Chief Executive Officer. Exempt under Rule 16b-3(d)."}],"balance_after":22500000,"source":{"system":"sec-edgar","filing":"0001493152-21-007920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315221007920/ownership.xml","form_type":"4"}},{"id":2975058,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-18T12:30:00.000Z","date":"2020-10-02","kind":"purchase","acquired":true,"shares":4000000,"price":0.0003,"value":1200.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Actual price paid for the shares were $0.00025 per share. The price reflected has been rounded up to the nearest decimal point."}],"balance_after":20000000,"source":{"system":"sec-edgar","filing":"0001493152-20-021911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315220021911/ownership.xml","form_type":"4"}},{"id":2975057,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-18T12:30:00.000Z","date":"2020-10-02","kind":"purchase","acquired":true,"shares":7000000,"price":0.0002,"value":1400.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"balance_after":16000000,"source":{"system":"sec-edgar","filing":"0001493152-20-021911","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315220021911/ownership.xml","form_type":"4"}},{"id":3114627,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-10T17:29:32.000Z","date":"2020-05-22","kind":"grant","acquired":true,"shares":3000000,"price":0.26,"value":780000.0,"ownership":{"direct":false,"nature":"Held by Cohen Enterprises, Inc"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Issued in consideration for services rendered as Chief Executive Officer. Exempt under Rule 16b-3(d)."}],"balance_after":9000000,"source":{"system":"sec-edgar","filing":"0001493152-20-010949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315220010949/ownership.xml","form_type":"4"}},{"id":3114626,"issuer":{"id":114347,"kind":"organization","name":"AMERICAN INTERNATIONAL HOLDINGS CORP.","symbol":"AMIH"},"owners":[{"id":56819,"kind":"person","name":"Cohen Jacob D.","position":1,"cik":"0001432078","reported_name":"Cohen Jacob D.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2020-06-10T17:29:32.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for services rendered as a member of the Board of Directors of the Issuer. Exempt under Rule 16b-3(d). There is no market for the share of Series A Preferred Stock, which share of Series A Preferred Stock, together with the other two outstanding shares of Series A Preferred Stock of the Issuer vote in aggregate sixty percent (60%) of the total vote on all shareholder matters, voting separately as a class."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for services rendered as a member of the Board of Directors of the Issuer. Exempt under Rule 16b-3(d). There is no market for the share of Series A Preferred Stock, which share of Series A Preferred Stock, together with the other two outstanding shares of Series A Preferred Stock of the Issuer vote in aggregate sixty percent (60%) of the total vote on all shareholder matters, voting separately as a class."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Series A Preferred Stock is described in greater detail in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on May 21, 2020."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001493152-20-010949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1432078/000149315220010949/ownership.xml","form_type":"4"}}]}